Acosta, Gabriel – Trademark Portfolio

Entity Type: 01

Acosta, Gabriel holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 4 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include EMB10YI, EMB LENDERS, and EMB S.S.T.M.. The owner is based in Weston, FL.

2209 N. Commerce Parkway

Weston, FL 33326

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Acosta, Gabriel's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (4 filings)

Education; providing of training; entertainment; sporting and cultural activities

36
Insurance & Financial (3 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Acosta, Gabriel have?

Acosta, Gabriel has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned, 2 cancelled.

What trademark classes does Acosta, Gabriel file in?

Acosta, Gabriel files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Acosta, Gabriel's most well-known trademarks?

Acosta, Gabriel's registered trademark portfolio includes well-known marks such as EMB10YI, EMB LENDERS, and EMB S.S.T.M.. These are among 3 currently registered trademarks in the portfolio.

What is Acosta, Gabriel's trademark registration success rate?

Acosta, Gabriel has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.